PBYI Insider Trading Activity and SEC Form 4 Filings
PBYI insider trading summary
Over the past 12 months, insiders at Puma Biotechnology, Inc. (PBYI) reported 17 sales worth $2.1M by 10 insiders and no open-market purchases on SEC Form 4. Net insider selling was $2.1M.
Latest PBYI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 14, 2026 | Alessandra Cesano | Director | Sell | $567K (62,150 @ $9.12) |
| Sep 14, 2026 | Troy Edward Wilson | Director | Sell | $46K (5,000 @ $9.10) |
| Jul 6, 2026 | Maximo F Nougues | Chief Financial Officer | Sell | $78K (9,386 @ $8.26) |
| Jul 6, 2026 | Douglas M Hunt | See Remarks | Sell | $70K (8,460 @ $8.26) |
| Jul 6, 2026 | Alan H Auerbach | President and CEO | Sell | $364K (44,058 @ $8.26) |
| Jun 12, 2026 | Adrian Senderowicz | Director | Sell | $194K (27,000 @ $7.20) |
| Jun 12, 2026 | Brian M Stuglik | Director | Sell | $58K (8,100 @ $7.20) |
| Jun 12, 2026 | Jay M Moyes | Director | Sell | $159K (22,000 @ $7.22) |
| Jun 12, 2026 | Troy Edward Wilson | Director | Sell | $78K (10,800 @ $7.20) |
| Jun 12, 2026 | Allison Dorval | Director | Sell | $84K (11,610 @ $7.20) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.